SCHEDULE: Wolverine Group Reports Zero Stake in Aimei Health
Beneficial Ownership Report Amendment
Wolverine Asset Management and its affiliates have filed an amended Schedule 13G, reporting zero beneficial ownership in Aimei Health Technology Co., Ltd.
Summary
- Wolverine Asset Management LLC, Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Christopher L. Gust, and Robert R. Bellick have filed an Amendment No. 2 to Schedule 13G.
- The reporting persons collectively hold 0.00 Ordinary Shares of Aimei Health Technology Co., Ltd., representing 0% of the class.
- This filing indicates that the reporting group has no sole or shared voting or dispositive power over any shares of the Issuer.
Sentiment
Score: 5
Explanation: The filing is a factual report of beneficial ownership, indicating a 0% stake, which is neutral in sentiment for the issuer based solely on this document.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Indicates that Wolverine Asset Management and its affiliated entities no longer hold a reportable beneficial ownership stake in Aimei Health Technology Co., Ltd., which may reflect a change in institutional investor interest.
Key Dates
| Date | Description |
|---|---|
| 11/03/2025 | Date of Event Which Requires Filing of this Statement |
| 11/07/2025 | Signature Date for Wolverine Asset Management LLC, Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Christopher L. Gust, and Robert R. Bellick |
Keywords
Aimei Health Technology, Wolverine Asset Management, Schedule 13G, beneficial ownership, equity stake, investment disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.